Crown Bioscience Revenue and Competitors

Location

$62.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Crown Bioscience's estimated annual revenue is currently $177.6M per year.(i)
  • Crown Bioscience's estimated revenue per employee is $248,000
  • Crown Bioscience's total funding is $62.1M.

Employee Data

  • Crown Bioscience has 716 Employees.(i)
  • Crown Bioscience grew their employee count by 13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Crown Bioscience Inc. is a US-based biomedical outsourcing company, providing efficient and cost-effective solutions for global biotech and pharmaceutical companies. Our company is headquartered in the heart of Silicon Valley, with a wholly owned research centers in Beijing China, and Indianapolis, US. We currently have 40,000 sq ft of modern biomedical research facility, including a 10,000 sq ft animal vivarium able to house immunodeficient small animals and large animal species. With China's large pool of well-trained scientists, doctors, and highly developed research infrastructures, our worldwide customers and partners realize increased efficiency, growth, and diversification by leveraging our ability to deliver cost-effective, high quality, and scalable biomedical outsourcing services.

keywords:N/A

$62.1M

Total Funding

716

Number of Employees

$177.6M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Crown Bioscience News

2022-04-19 - Life Science Products Market Size, Scope And Forecast ...

Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS BIOSCIENCE INC., Crown Bioscience Inc., GENSCRIPT BIOTECH CORPORATION, Merck...

2022-04-17 - Drug Modeling Software Market to Perceive Substantial ...

Drug Modeling Software Market to Perceive Substantial Growth During 2022-2029 | Crown Bioscience, Nimbus, Schrodinger. Drug Modeling Software Market is...

2022-04-17 - Expert Insight: Evaluating oncology drugs in patient tumors ...

Nataliia Beztsinna, from Crown Bioscience, reviews the benefits of a novel 3D Ex Vivo Patient Tissue Platform that uses freshly collected...

2021-10-08 - JSR : Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform' to Improve Predictability of Immuno-Oncology Drug Candidates

October 8, 2021 - Crown Bioscience, a JSR Life Sciences Company, announced the launch of its '3D Ex Vivo Patient Tissue Platform' to improve predictability of immuno-oncology drug candidates. For more information on Crown Bioscience's 3D Ex Vivo Patient Tissue Platform, visit Crown Bioscience's ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M71749%N/A
#2
$229.5M722N/AN/A
#3
$254.1M7261%N/A
#4
$152.9M728-1%N/A
#5
$257.6M73631%N/A